The effects of substituted cyclodextrins on the colloidal and conformational stability of selected proteins

Journal of Pharmaceutical Sciences

Volumn 99, Issue 6, 2010, Pages 2800-2818

  Samra, Hardeep S ^a,c   He, Feng ^a,d   Bhambhani, Akhilesh ^a,e   Pipkin, J D ^b   Zimmerer, Roz ^b   Joshi, Sangeeta B ^a   Middaugh, C Russell ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b CyDex LC   (United States)

^c MEDIMMUNE   (United States)

^d AMGEN INC   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Biotechnology; Cyclodextrins; Formulation; Protein aggregation; Protein formulation; Protein structure; Stability; Structure

Indexed keywords

CYCLODEXTRIN DERIVATIVE;

ARTICLE; DRUG STABILITY; FLUORESCENCE SPECTROSCOPY; LIGHT SCATTERING; PH; TEMPERATURE;

EID: 77951605340     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22053     Document Type: Article

References (42)

1. Manning MC, Patel K, Borchardt RT. 1989. Stability of protein pharmaceuticals. Pharm Res 6:903-918.
2. Wang W. 2005. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm 289:1-30.
3. Brewster ME, Hora MS, Simpkins JW, Bodor N. 1991. Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs. Pharm Res 8:792-795.
4. Loftsson T, Brewster ME. 1996. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85:1017-1025.
5. Szente L, Szejtli J. 1999. Highly soluble cyclodextrin derivatives: Chemistry, properties, and trends in development. Adv Drug Deliv Rev 36:17-28.
6. Stella VJ, Rajewski RA. 1997. Cyclodextrins: Their future in drug formulation and delivery. Pharm Res 14:556-567.
7. Irie T, Uekama K. 1997. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 86:147-162.
8. Luna EA, Bornancini ER, Tait RJ, Thompson DO, Stobaugh JF, Rajewski RA, Stella VJ. 1996. Evaluation of the utility of capillary electrophoresis for the analysis of sulfobutyl ether beta-cyclodextrin mixtures. J Pharm Biomed Anal 15:63-71.
9. Zia V, Rajewski RA, Bornancini ER, Luna EA, Stella VJ. 1997. Effect of alkyl chain length and degree of substitution on the complexation of sulfoalkyl ether beta-cyclodextrins with steroids. J Pharm Sci 86:220-224.
10. Zia V, Rajewski RA, Stella VJ. 2000. Thermodynamics of binding of neutral molecules to sulfobutyl ether beta-cyclodextrins (SBE-beta-CDs): The effect of total degree of substitution. Pharm Res 17:936-941.
11. Bodor NS, Huang MJ, Watts JD. 1995. Theoretical studies on the structures of natural and alkylated cyclodextrins. J Pharm Sci 84:330-336.
12. Botsi A, Yannakopoulou K, Hadjoudis E. 1993. Inclusion complexes of cyclomaltoheptaose (beta-cyclodextrin) and its methylated derivatives with the main components of the pheromone of the olive fruit fly. Carbohydr Res 241:37-46.
13. Brewster ME, Anderson WR, Loftsson T, Huang MJ, Bodor N, Pop E. 1995. Preparation, characterization, and anesthetic properties of 2-hydroxypropyl- beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse. J Pharm Sci 84:1154-1159.
14. Liu L, Guo Q-X. 2002. The driving forces in the inclusion complexation of cyclodextrins. J Inclusion Phenom. Macro Chem 42:1-14.
15. Liu Y, Li B, Wada T, Inoue Y. 2001. Fluorometric studies on inclusion complexation of L/D-tryptophan by beta-cyclodextrin 6-O-pyridinecarboxylates. Bioorg Chem 29:19-26.
16. Maletic M, McDonald DQ, Breslow R, Still WC. 1996. Selective binding of the dipeptides L-Phe-D-Pro and D-Phe-L-Pro to beta-cyclodextrin. Angew Chem Int Ed 35:1490-1492.
17. Breslow R, Yang Z, Ching R, Trojandt G, Odobel F. 1998. Sequence selective binding of peptides by artificial receptors in aqueous solution. J Am Chem Soc 120:3536-3537.
18. Cooper A. 1992. Effect of cyclodextrins on the thermal stability of globular proteins. J Am Chem Soc 114:9208-9209.
19. Horsky J, Pitha J. 1994. Inclusion complexes of proteins: Interaction of cyclodextrins with peptides containing aromatic amino acids studied by competitive spectroscopy. J Incl Phenom Mol Recognit Chem 18:291-300.
20. Zia V, Rajewski RA, Stella VJ. 2001. Effect of cyclodextrin charge on complexation of neutral and charged substrates: Comparison of (SBE)7M-beta-CD to HP-beta-CD. Pharm Res 18:667-673.
21. Aachmann FL, Otzen DE, Larsen KL, Wimmer R. 2003. Structural background of cyclodextrin-protein interactions. Protein Eng 16:905-912.
22. Otzen DE, Knudsen BR, Aachmann F, Larsen KL, Wimmer R. 2002. Structural basis for cyclodextrins' suppression of human growth hormone aggregation. Protein Sci 11:1779-1787.
23. Katakam M, Banga AK. 1995. Aggregation of proteins and its prevention by carbohydrate excipients: Albumins and gamma-globulin. J Pharm Pharmacol 47:103-107.
24. Charman SA, Mason KL, Charman WN. 1993. Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone. Pharm Res 10:954-962.
25. Karuppiah N, Sharma A. 1995. Cyclodextrins as protein folding aids. Biochem Biophys Res Commun 211:60-66.
26. Iwai J, Ogawa N, Nagase H, Endo T, Loftsson T, Ueda H. 2007. Effects of various cyclodextrins on the stability of freeze-dried lactate dehydrogenase. J Pharm Sci 96:3140-3143.
27. Izutsu K, Yoshioka S, Kojima S. 1995. Increased stabilizing effects of amphiphilic excipients on freeze-drying of lactate dehydrogenase (LDH) by dispersion into sugar matrices. Pharm Res 12:838-843.
28. Banga AK, Mitra R. 1993. Minimization of shaking-induced formation of insoluble aggregates of insulin by cyclodextrins. J Drug Target 1:341-345.
29. Tokihiro K, Arima H, Tajiri S, Irie T, Hirayama F, Uekama K. 2000. Improvement of subcutaneous bioavailability of insulin by sulphobutyl ether beta-cyclodextrin in rats. J Pharm Pharmacol 52:911-917.
30. Tavornvipas S, Hirayama F, Takeda S, Arima H, Uekama K. 2006. Effects of cyclodextrins on chemically and thermally induced unfolding and aggregation of lysozyme and basic fibroblast growth factor. J Pharm Sci 95:2722-2729.
31. Derrick T, Grillo AO, Vitharana SN, Jones L, Rexroad J, Shah A, Perkins M, Spitznagel TM, Middaugh CR. 2007. Effect of polyanions on the structure and stability of repifermin (keratinocyte growth factor-2). J Pharm Sci 96:761-776.
32. Espina M, Ausar SF, Middaugh CR, Baxter MA, Picking WD, Picking WL. 2007. Conformational stability and differential structural analysis of LcrV, PcrV, BipD, and SipD from type III secretion systems. Protein Sci 16:704-714.
33. Kamerzell TJ, Unruh JR, Johnson CK, Middaugh CR. 2006. Conformational flexibility, hydration and state parameter fluctuations of fibroblast growth factor-10: Effects of ligand binding. Biochemistry 45:15288-15300.
34. Markham AP, Birket SE, Picking WD, Picking WL, Middaugh CR. 2008. pH sensitivity of type III secretion system tip proteins. Proteins 71:1830-1842.
35. Salnikova MS, Joshi SB, Rytting JH, Warny M, Middaugh CR. 2008. Physical characterization of clostridium difficile toxins and toxoids: Effect of the formaldehyde crosslinking on thermal stability. J Pharm Sci 97:3735-3752.
36. Salnikova MS, Joshi SB, Rytting JH, Warny M, Middaugh CR. 2008. Preformulation studies of Clostridium difficile toxoids A and B. J Pharm Sci 97:4194-4207.
37. Cai S, He F, Samra HS, de la Maza LM, Bottazzi ME, Joshi SB, Middaugh CR. 2009. Biophysical and Stabilization Studies of the Chlamydia trachomatis Mouse Pneumonitis Major Outer Membrane Protein. Mol Pharm 6:1553-1561.
38. Sougioultzis S, Kyne L, Drudy D, Keates S, Maroo S, Pothoulakis C, Giannasca PJ, Lee CK, Warny M, Monath TP, Kelly CP. 2005. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology 128:764-770.
39. Copeland RA, Ji H, Halfpenny AJ, Williams RW, Thompson JC, Herber WK, Thomas KA, Bruner MW, Ryan JA, Marquis-Omer D, Sanyal G, Sitrin RD, Yamasaki S, Middaugh CR. 1991. The structure of human acidic fibroblast growth factor and its interaction with heparin. Arch Biochem Biophys 289:53-61.
40. Arakawa T, Timasheff SN. 1982. Stabilization of protein structure by sugars. Biochemistry 21:6536-6544.
41. Gekko K, Morikawa T. 1981. Preferential hydration of bovine serum albumin in polyhydric alcohol-water mixtures. J Biochem 90:39-50.
42. Serno T, Carpenter JF, Randolph TW, Winter G. 2009. Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta- cyclodextrin. J Pharm Sci.